PS Ratio Chart

Historical PS Ratio Data

View and export this data back to 2008. Start Trial.
Date Value
November 17, 2026 2.920
November 16, 2026 2.920
November 13, 2026 2.920
November 12, 2026 2.920
November 11, 2026 2.920
November 10, 2026 2.920
November 09, 2026 2.920
November 06, 2026 2.826
November 05, 2026 2.826
November 04, 2026 2.826
November 03, 2026 2.826
November 02, 2026 2.826
October 30, 2026 2.826
October 29, 2026 2.826
October 28, 2026 2.826
October 27, 2026 2.826
October 26, 2026 2.826
October 23, 2026 2.826
October 22, 2026 2.826
October 21, 2026 2.826
October 20, 2026 2.826
October 19, 2026 2.826
October 16, 2026 2.826
October 15, 2026 2.826
October 14, 2026 2.826
Date Value
October 13, 2026 2.826
October 12, 2026 2.826
October 09, 2026 2.826
October 08, 2026 2.826
October 07, 2026 2.638
October 06, 2026 2.638
October 05, 2026 2.638
October 02, 2026 2.638
October 01, 2026 2.638
September 30, 2026 2.638
September 29, 2026 2.668
September 28, 2026 2.582
September 25, 2026 2.582
September 24, 2026 2.582
September 23, 2026 2.582
September 22, 2026 2.582
September 21, 2026 2.582
September 18, 2026 2.582
September 17, 2026 2.582
September 16, 2026 2.582
September 15, 2026 2.582
September 14, 2026 2.582
September 11, 2026 2.582
September 10, 2026 2.582
September 09, 2026 2.582

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Evaxion AS 2.545
Genmab A/S 7.572
Ascendis Pharma A/S 12.72
Zealand Pharma A/S 3.520
Agenus, Inc. 2.364

PS Ratio Related Metrics